ClinicalTrials.govpublic full text
Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment
hepatitis c, chronic hepatitis c, cyclophilin inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010455
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.